scholarly journals Galectin-3: clinical utility and prognostic value in patients with heart failure

2013 ◽  
pp. 13 ◽  
Author(s):  
Frank Kramer
Keyword(s):  
Heart Failure ◽  
Prognostic Value ◽  
Clinical Utility ◽  
Patients With Heart Failure ◽  
Galectin 3

scholarly journals Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart Failure

2013 ◽  
Vol 6 (2) ◽  
pp. 219-226 ◽  
Author(s):  
A. Rogier van der Velde ◽  
Lars Gullestad ◽  
Thor Ueland ◽  
Pål Aukrust ◽  
Yu Guo ◽  
...  
Keyword(s):  
Heart Failure ◽  
Prognostic Value ◽  
Patients With Heart Failure ◽  
Galectin 3 ◽  
Over Time

Prognostic value of galectin-3 on admission in Chinese patients with heart failure: a prospective observational study

2017 ◽  
Vol 72 (2) ◽  
pp. 188-195 ◽  
Author(s):  
Hua Wang ◽  
Qingyong Chen ◽  
Yingying Li ◽  
Xianchao Jing ◽  
Tianya Liang ◽  
...  
Keyword(s):  
Heart Failure ◽  
Observational Study ◽  
Prognostic Value ◽  
Prospective Observational Study ◽  
Chinese Patients ◽  
Patients With Heart Failure ◽  
Galectin 3

scholarly journals Prognostic Value of Galectin-3 in Patients with Heart Failure

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Ivica Bošnjak ◽  
Kristina Selthofer-Relatić ◽  
Aleksandar Včev
Keyword(s):  
Heart Failure ◽  
Prognostic Value ◽  
Disease Modifying Drugs ◽  
Reduced Ejection Fraction ◽  
Patients With Heart Failure ◽  
Galectin 3 ◽  
Myocardial Remodelling ◽  
Lectin Family ◽  
Disease Modifying

Galectins are a family of solubleβ-galactoside-binding lectins that have important role in inflammation, immunity, and cancer. Galectin-3 as a part of this lectin family plays a very important role in development of heart failure. According to recent papers, galectin-3 plasma level correlates with heart failure outcome, primarily with rehospitalisation and death from heart failure. This paper summarizes the most recent advances in galectin-3 research, with the accent on the role of galectin-3 in pathophysiology of myocardial remodelling and heart failure development—with preserved and reduced ejection fraction, and some implication on development of new disease modifying drugs.

scholarly journals Metabolic profile provides prognostic value better than galectin-3 in patients with heart failure

2017 ◽  
Vol 70 (1) ◽  
pp. 92-98 ◽  
Author(s):  
Chao-Hung Wang ◽  
Mei-Ling Cheng ◽  
Min-Hui Liu ◽  
Li-Tang Kuo ◽  
Ming-Shi Shiao
Keyword(s):  
Heart Failure ◽  
Metabolic Profile ◽  
Prognostic Value ◽  
Patients With Heart Failure ◽  
Galectin 3 ◽  
Better Than

Prognostic value of serum galectin-3 in patients with heart failure: A meta-analysis

2015 ◽  
Vol 182 ◽  
pp. 168-170 ◽  
Author(s):  
Ao Chen ◽  
Wolin Hou ◽  
Yunhe Zhang ◽  
Yingmin Chen ◽  
Ben He
Keyword(s):  
Heart Failure ◽  
Prognostic Value ◽  
Meta Analysis ◽  
Patients With Heart Failure ◽  
Galectin 3
Sign in / Sign up

Export Citation Format

Share Document